- Home
- GNTA vs MDCX Comparison
GNTA vs MDCX Comparison
Compare GNTA & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.01
Company Overview
Basic Information| Metric | GNTA | MDCX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 31.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNTA | MDCX |
|---|---|---|
| Price | $1.01 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | ★ 3.0M | 282.2K |
| Earning Date | 03-24-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.06 | $1.14 |
| 52 Week High | $10.00 | $8.94 |
Technical Indicators
Market Signals| Indicator | GNTA | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 31.60 | 29.65 |
| Support Level | $1.26 | $1.14 |
| Resistance Level | $1.70 | $1.29 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.22 | 11.39 |
Price Performance
Historical Comparison GNTA
MDCX
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.